Patent · US Active

4′-azido, 3′-deoxy-3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replication

US9249176B2 · kind B2 · utility

1Cited by

7References

20Claims

0Family size

Assignee

Riboscience LLC · US

Inventors

Mark Smith · Saffron Walden, GB
Klaus G. Klumpp · West Chester, US

Key dates

Filing date	May 15, 2014
Grant date	Feb 2, 2016
Priority date	—
Expiry date	May 15, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07H19/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to the compound of Formula I:Also disclosed are pharmaceutical compositions comprising the compound of Formula I, methods of using the compound of Formula I and/or compositions comprising the compound of Formula I for the treatment of HCV.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.